The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
High-throughput exome array for identification of novel polymorphisms associated with clinical outcome in mCRC patients treated with first-line FOLFOXIRI/BEV versus FOLFIRI/BEV (TRIBE trial; NCT00719797).
Wu Zhang
No relevant relationships to disclose
Fredrick Schumacher
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
David van Den Berg
No relevant relationships to disclose
Chiara Cremolini
No relevant relationships to disclose
Sebastian Stintzing
No relevant relationships to disclose
Yan Ning
No relevant relationships to disclose
Ana Sebio
No relevant relationships to disclose
Stefan Stremitzer
No relevant relationships to disclose
Yu Sunakawa
No relevant relationships to disclose
Satoshi Matsusaka
No relevant relationships to disclose
Shinichi Yamauchi
No relevant relationships to disclose
Rita Elkhoueiry
No relevant relationships to disclose
Alfredo Falcone
No relevant relationships to disclose
Heinz-Josef Lenz
No relevant relationships to disclose